SCHEMBL26435965

SCHEMBL26435965

c1ccc(-c2nc(-c3cc(-c4cc5ccccc5c5ccccc45)cc(-c4cc5ccccc5c5ccccc45)c3)nc(-c3cc4ccccc4c4ccccc34)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.51
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 4/20 0.43
KDM4E B2RXH2 3/20 0.43
MPI P34949 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 1/20 0.40
TSHR P16473 3/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
ADORA3 P0DMS8 2/20 0.39
ADORA2B P29275 2/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9958660 0.96 CYP11B1 (0.54) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL18878261 0.93 CYP11B1 (0.51) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL18533197 0.93 CYP11B1 (0.51) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL31369124 0.93 CYP11B1 (0.51) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL17932616 0.93 CYP11B1 (0.47) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL17932319 0.93 CYP11B1 (0.51) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL19271420 0.93 CYP11B1 (0.53) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL18327468 0.93 CYP11B1 (0.53) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL23065684 0.92 CYP11B1 (0.50) CYP11B1ALDH1A1MEN1KMT2AMAPT
SCHEMBL24306472 0.92 CYP11B1 (0.50) CYP11B1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 CYP11B1 2325/4885ALDH1A1 1532/4885MEN1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.